SCHEMBL16809390

SCHEMBL16809390

CC(c1oc(=O)c2ccccc2c1C1=CCNCC1)n1nc(I)c2c(N)ncnc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 10/20 0.37
▸ PIK3CG P48736 3/20 0.35
▸ PIK3R1 P27986 1/20 0.35
▸ CSNK1E P49674 1/20 0.35
▸ KDR P35968 2/20 0.34
▸ RET P07949 1/20 0.34
▸ ATR Q13535 1/20 0.33
▸ HTR6 P50406 2/20 0.33
▸ SRC P12931 5/20 0.33
▸ ABL1 P00519 3/20 0.33
▸ HCK P08631 2/20 0.33
▸ PIK3CB P42338 3/20 0.32
▸ PIK3CA P42336 2/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ EGFR P00533 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ EPHB4 P54760 1/20 0.32
▸ PI4KB Q9UBF8 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16783511 0.99 PIK3CD (0.36) PIK3CDPIK3CGPIK3R1CSNK1EKDR
SCHEMBL21337782 0.92 PIK3CD (0.40) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CB
SCHEMBL16806425 0.85 PIK3CD (0.37) PIK3CDPIK3CGPIK3R1CSNK1EKDR
Hydrochloric Acid SCHEMBL16783635 0.85 PIK3CD (0.36) PIK3CDPIK3CGPIK3R1CSNK1EKDR
SCHEMBL16783686 0.84 PIK3CD (0.44) PIK3CDPIK3CGPIK3R1CSNK1EKDR
SCHEMBL16783500 0.83 PIK3CD (0.52) PIK3CDPIK3CGPIK3R1CSNK1EKDR
SCHEMBL16783442 0.83 PIK3CD (0.35) PIK3CDPIK3CGPIK3R1CSNK1ERET
SCHEMBL16783662 0.83 PIK3CD (0.35) PIK3CDPIK3CGPIK3R1CSNK1ERET
SCHEMBL16783414 0.83 PIK3CD (0.44) PIK3CDPIK3CGPIK3R1CSNK1EKDR
Hydrochloric Acid SCHEMBL16783715 0.83 PIK3CD (0.51) PIK3CDPIK3CGPIK3R1CSNK1EKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3083617-B1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARM SPA (IT) 2019-09-11 — — EP disclosed
US-9321776-B2 Isochromene derivatives as phoshoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-04-26 — — US disclosed
WO-2015091685-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-25 — — WO disclosed
US-20150166549-A1 ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166549-A1 ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, IP6K2, IP6K3 PIK3CD 15/4885PIK3CG 23/4885PIK3R1 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback